Your search returned 7 results.

Results
	1.	Evaluation of plasma Abeta40 and Abeta42 as predictors of conversion to Alzheimer's disease in patients with mild cognitive impairment. [electronic resource] by Kester, Maartje I Verwey, Nicolaas A van Elk, Evert J Scheltens, Philip Blankenstein, Marinus A Producer: 20100608 In: Neurobiology of aging vol. 31 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	2.	Progression from MCI to AD: predictive value of CSF Aβ42 is modified by APOE genotype. [electronic resource] by Kester, Maartje I Verwey, Nicolaas A van Elk, Evert J Blankenstein, Marinus A Scheltens, Philip van der Flier, Wiesje M Producer: 20120514 In: Neurobiology of aging vol. 32 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	3.	CSF biomarkers in Alzheimer's disease and controls: associations with APOE genotype are modified by age. [electronic resource] by Kester, Maartje I Blankenstein, Marinus A Bouwman, Femke H van Elk, Evert J Scheltens, Philip van der Flier, Wiesje M Producer: 20090518 In: Journal of Alzheimer's disease : JAD vol. 16 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	4.	Usefulness of longitudinal measurements of beta-amyloid1-42 in cerebrospinal fluid of patients with various cognitive and neurologic disorders. [electronic resource] by Bouwman, Femke H van der Flier, Wiesje M Schoonenboom, Niki S M van Elk, Evert J Kok, Astrid Scheltens, Philip Blankenstein, Marinus A Producer: 20060829 In: Clinical chemistry vol. 52 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	5.	Amyloid-beta(1-42), total tau, and phosphorylated tau as cerebrospinal fluid biomarkers for the diagnosis of Alzheimer disease. [electronic resource] by Mulder, Cees Verwey, Nicolaas A van der Flier, Wiesje M Bouwman, Femke H Kok, Astrid van Elk, Evert J Scheltens, Philip Blankenstein, Marinus A Producer: 20100304 In: Clinical chemistry vol. 56 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	6.	CSF biomarker levels in early and late onset Alzheimer's disease. [electronic resource] by Bouwman, Femke H Schoonenboom, Niki S M Verwey, Nicolaas A van Elk, Evert J Kok, Astrid Blankenstein, Marinus A Scheltens, Philip van der Flier, Wiesje M Producer: 20100111 In: Neurobiology of aging vol. 30 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	7.	Diagnostic impact of CSF biomarkers in a local hospital memory clinic. [electronic resource] by Kester, Maartje I Boelaarts, Leo Bouwman, Femke H Vogels, Raymond L Groot, Erwin R van Elk, Evert J Blankenstein, Marinus A van der Flier, Wiesje M Scheltens, Philip Producer: 20101208 In: Dementia and geriatric cognitive disorders vol. 29 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)